REFERENCES
1. Garcia M, Mulvagh SL, Merz CN, Buring JE, Manson JE. Cardiovascular disease in women: clinical perspectives. Circ Res 2016;118:1273-93.
2. Calabrò P, Niccoli G, Gragnano F, et al. Working Group of Interventional Cardiology of the Italian Society of Cardiology. Are we ready for a gender-specific approach in interventional cardiology? Int J Cardiol 2019;286:226-33.
3. Iung B, Delgado V, Rosenhek R, et al. EORP VHD II Investigators. Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II Survey. Circulation 2019;140:1156-69.
4. Baumgartner H, Falk V, Bax JJ, et al. ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91.
5. Virani SS, Alonso A, Benjamin EJ, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation 2020;141:e139-596.
6. Shames S, Gillam LD. Sex differences in aortic valve calcification. Circ Cardiovasc Imaging 2013;6:8-10.
7. Summerhill VI, Moschetta D, Orekhov AN, Poggio P, Myasoedova VA. Sex-specific features of calcific aorticvalve disease. Int J Mol Sci 2020;21:5620.
8. Chandrasekhar J, Dangas G, Mehran R. Valvular heart disease in women, differential remodeling, and response to new therapies. Curr Treat Options Cardiovasc Med 2017;19:74.
9. Cramariuc D, Rogge BP, Lønnebakken MT, et al. Sex differences in cardiovascular outcome during progression of aortic valve stenosis. Heart 2015;101:209-14.
10. Nguyen V, Mathieu T, Melissopoulou M, et al. Sex differences in the progression of aortic stenosis and prognostic implication: the COFRASA-GENERAC Study. JACC Cardiovasc Imaging 2016;9:499-501.
11. McNeely C, Vassileva C. Mitral valve surgery in women: another target for eradicating sex inequality. Circ Cardiovasc Qual Outcomes 2016;9:S94-6.
12. Tribouilloy C, Bohbot Y, Rusinaru D, et al. Excess mortality and undertreatment of women with severe aortic stenosis. J Am Heart Assoc 2021;10:e018816.
13. Généreux P, Stone GW, O'Gara PT, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol 2016;67:2263-88.
14. Steeds RP, Messika-Zeitoun D, Thambyrajah J, et al. IMPULSE registry group. IMPULSE: the impact of gender on the presentation and management of aortic stenosis across Europe. Open Heart 2021;8:e001443.
15. Singh A, Chan DCS, Greenwood JP, et al. Symptom onset in aortic stenosis: relation to sex differences in left ventricular remodeling. JACC Cardiovasc Imaging 2019;12:96-105.
16. Dobson LE, Musa TA, Uddin A, et al. Gender influences left ventricular remodelling in the setting of aortic stenosis but does not appear to impact on reverse remodelling following transcatheter aortic valve implantation. J Cardiovasc Magn Reson 2015;17:P332.
17. Bech-hanssen O, Wallentin I, Houltz E, Beckman Suurküla M, Larsson S, Caidahl K. Gender differences in patients with severe aortic stenosis: impact on preoperative left ventricular geometry and function, as well as early postoperative morbidity and mortality. Eur J Cardiothorac Surg 1999;15:24-30.
18. Chin CW, Khaw HJ, Luo E, et al. Echocardiography underestimates stroke volume and aortic valve area: implications for patients with small-area low-gradient aortic stenosis. Can J Cardiol 2014;30:1064-72.
19. Michelena HI, Margaryan E, Miller FA, et al. Inconsistent echocardiographic grading of aortic stenosis: is the left ventricular outflow tract important? Heart 2013;99:921-31.
20. Pibarot P, Dumesnil JG. Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. J Am Coll Cardiol 2012;60:1845-53.
21. Tastet L, Kwiecinski J, Pibarot P, et al. Sex-related differences in the extent of myocardial fibrosis in patients with aortic valve stenosis. JACC Cardiovasc Imaging 2020;13:699-711.
22. Boulif J, Gerber B, Slimani A, et al. Assessment of aortic valve calcium load by multidetector computed tomography. Anatomical validation, impact of scanner settings and incremental diagnostic value. J Cardiovasc Comput Tomogr 2017;11:360-6.
23. Nguyen V, Cimadevilla C, Estellat C, et al. Haemodynamic and anatomic progression of aortic stenosis. Heart 2015;101:943-7.
24. Tuncay V, Prakken N, van Ooijen PM, Budde RP, Leiner T, Oudkerk M. Semiautomatic, quantitative measurement of aortic valve area using CTA: validation and comparison with transthoracic echocardiography. Biomed Res Int 2015;2015:648283.
25. Kamperidis V, van Rosendael PJ, Katsanos S, et al. Low gradient severe aortic stenosis with preserved ejection fraction: reclassification of severity by fusion of Doppler and computed tomographic data. Eur Heart J 2015;36:2087-96.
26. Clavel MA, Pibarot P, Messika-Zeitoun D, et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol 2014;64:1202-13.
27. Nchimi A, Dibato JE, Davin L, Schoysman L, Oury C, Lancellotti P. Predicting disease progression and mortality in aortic stenosis: a systematic review of imaging biomarkers and meta-analysis. Front Cardiovasc Med 2018;5:112.
28. Pradelli D, Faden G, Mureddu G, et al. Impact of aortic or mitral valve sclerosis and calcification on cardiovascular events and mortality: a meta-analysis. Int J Cardiol 2013;170:e51-5.
29. Di Minno MND, Poggio P, Conte E, et al. Cardiovascular morbidity and mortality in patients with aortic valve calcification: a systematic review and meta-analysis. J Cardiovasc Comput Tomogr 2019;13:190-5.
30. Myasoedova VA, Di Minno A, Songia P, et al. Sex-specific differences in age-related aortic valve calcium load: a systematic review and meta-analysis. Ageing Res Rev 2020;61:101077.
31. Cueff C, Serfaty JM, Cimadevilla C, et al. Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart 2011;97:721-6.
32. Clavel MA, Messika-Zeitoun D, Pibarot P, et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. J Am Coll Cardiol 2013;62:2329-38.
33. Voisine M, Hervault M, Shen M, et al. Age, sex, and valve phenotype differences in fibro-calcific remodeling of calcified aortic valve. J Am Heart Assoc 2020;9:e015610.
34. Kvidal P, Bergström P, Hörte L, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000;35:747-56.
35. Otto CM, Nishimura RA, Bonow RO, et al. Writing Committee Members. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;77:450-500.
36. Singh A, Musa TA, Treibel TA, et al. Sex differences in left ventricular remodelling, myocardial fibrosis and mortality after aortic valve replacement. Heart 2019;105:1818-24.
38. Pighi M, Piazza N, Martucci G, et al. Sex-specific determinants of outcomes after transcatheter aortic valve replacement. Circ Cardiovasc Qual Outcomes 2019;12:e005363.
39. O'Connor SA, Morice MC, Gilard M, et al. Revisiting sex equality with transcatheter aortic valve replacement outcomes: a collaborative, patient-level meta-analysis of 11,310 patients. J Am Coll Cardiol 2015;66:221-8.
40. Kataruka A, Otto CM. Valve durability after transcatheter aortic valve implantation. J Thorac Dis 2018;10:S3629-36.
41. Onorati F, D'Errigo P, Barbanti M, et al. OBSERVANT Research Group. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter Italian OBSERVANT Registry. J Thorac Cardiovasc Surg 2014;147:1529-39.
42. Chaker Z, Badhwar V, Alqahtani F, et al. Sex differences in the utilization and outcomes of surgical aortic valve replacement for severe aortic stenosis. J Am Heart Assoc 2017;6:e006370.
43. Fuchs C, Mascherbauer J, Rosenhek R, et al. Gender differences in clinical presentation and surgical outcome of aortic stenosis. Heart 2010;96:539-45.
44. Milavetz DL, Hayes SN, Weston SA, Seward JB, Mullany CJ, Roger VL. Sex differences in left ventricular geometry in aortic stenosis: impact on outcome. Chest 2000;117:1094-9.
46. Tarantini G, Baumgartner H, Frank D, et al. Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3. Catheter Cardiovasc Interv 2021;97:876-84.
47. Chieffo A, Petronio AS, Mehilli J, et al. WIN-TAVI Investigators. Acute and 30-day outcomes in women after TAVR: results from the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) real-world registry. JACC Cardiovasc Interv 2016;9:1589-600.
48. Chieffo A, Petronio AS, Mehilli J, et al. WIN-TAVI Investigators. 1-year clinical outcomes in women after transcatheter aortic valve replacement: results from the first WIN-TAVI registry. JACC Cardiovasc Interv 2018;11:1-12.
49. Saad M, Nairooz R, Pothineni NVK, et al. Long-term outcomes with transcatheter aortic valve replacement in women compared with men: evidence from a meta-analysis. JACC Cardiovasc Interv 2018;11:24-35.
50. Szerlip M, Gualano S, Holper E, et al. Sex-specific outcomes of transcatheter aortic valve replacement with the SAPIEN 3 valve: insights from the PARTNER II S3 high-risk and intermediate-risk cohorts. JACC Cardiovasc Interv 2018;11:13-20.
51. Wang TY, Gracia E, Callahan S, et al. Gender disparities in management and outcomes following transcatheter aortic valve implantation with newer generation transcatheter valves. Am J Cardiol 2019;123:1489-93.
52. Leon MB, Smith CR, Mack MJ, et al. PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609-20.
53. Ruge H, Burri M, Erlebach M, Lange R. Access site related vascular complications with third generation transcatheter heart valve systems. Catheter Cardiovasc Interv 2021;97:325-32.
54. Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 2012;59:113-8.
55. Di Mario C, Goodwin M, Ristalli F, et al. A prospective registry of intravascular lithotripsy-enabled vascular access for transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv 2019;12:502-4.
56. Dencker D, Taudorf M, Luk NH, et al. Frequency and effect of access-related vascular injury and subsequent vascular intervention after transcatheter aortic valve replacement. Am J Cardiol 2016;118:1244-50.
57. Witberg G, Tzalamouras V, Adams H, et al. Routine ultrasound or fluoroscopy use and risk of vascular/bleeding complications after transfemoral TAVR. JACC Cardiovasc Interv 2020;13:1460-8.
58. Power D, Schäfer U, Guedeney P, et al. Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: a post hoc analysis from the BRAVO-3 randomized trial. Catheter Cardiovasc Interv 2019;93:1374-81.
59. Buchanan GL, Chieffo A, Montorfano M, et al. A “modified crossover technique” for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2013;81:579-83.
60. Claessen BE, Tang GHL, Kini AS, Sharma SK. Considerations for optimal device selection in transcatheter aortic valve replacement: a review. JAMA Cardiol 2021;6:102-12.
61. Lee M, Modine T, Piazza N, Mylotte D. TAVI device selection: time for a patient-specific approach. EuroIntervention 2016;12:Y37-41.
62. Fischer Q, Urena M, Bouleti C, et al. Performing optimal transcatheter aortic valve implantation: the need for tailored use of transcatheter valves. Arch Cardiovasc Dis 2019;112:512-22.
63. Renker M, Kim WK. Choice of transcatheter heart valve: should we select the device according to each patient's characteristics or should it be “one valve fits all”? Ann Transl Med 2020;8:961.
64. Faquir N, Ren B, Van Mieghem NM, Bosmans J, de Jaegere PP. Patient-specific computer modelling - its role in the planning of transcatheter aortic valve implantation. Neth Heart J 2017;25:100-5.
65. Abdelghani M, Mankerious N, Allali A, et al. Bioprosthetic valve performance after transcatheter aortic valve replacement with self-expanding versus balloon-expandable valves in large versus small aortic valve annuli: insights from the CHOICE trial and the CHOICE-extend registry. JACC Cardiovasc Interv 2018;11:2507-18.
66. Hase H, Yoshijima N, Yanagisawa R, et al. OCEAN-TAVI Investigators. Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: the OCEAN-TAVI registry. Catheter Cardiovasc Interv 2021;97:E875-86.
67. Lanz J, Kim W, Walther T, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet 2019;394:1619-28.
68. Mauri V, Kim WK, Abumayyaleh M, et al. Short-term outcome and hemodynamic performance of next-generation self-expanding versus balloon-expandable transcatheter aortic valves in patients with small aortic annulus: a multicenter propensity-matched comparison. Circ Cardiovasc Interv 2017;10:e005013.
69. Debry N, Sudre A, Amr G, et al. Transcatheter aortic valve implantation for paradoxical low-flow low-gradient aortic stenosis patients. Catheter Cardiovasc Interv 2016;87:797-804.
70. Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol 2013;62:1552-62.
71. Nai Fovino L, Scotti A, Massussi M, et al. Incidence and feasibility of coronary access after transcatheter aortic valve replacement. Catheter Cardiovasc Interv 2020;96:E535-41.
72. Nai Fovino L, Scotti A, Massussi M, et al. Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after TAVR-in-TAVR. J Am Heart Assoc 2020;9:e016446.
73. Fontana GP, Bedogni F, Groh M, et al. Safety profile of an intra-annular self-expanding transcatheter aortic valve and next-generation low-profile delivery system. JACC Cardiovasc Interv 2020;13:2467-78.
74. van Gils L, Tchetche D, Latib A, et al. TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery. EuroIntervention 2016;12:Y22-7.
75. Reardon MJ, Van Mieghem NM, Popma JJ, et al. SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321-31.
76. Mack MJ, Leon MB, Thourani VH, et al. PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695-705.
77. Brouwer J, Nijenhuis VJ, Delewi R, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med 2020;383:1447-57.
78. Nijenhuis VJ, Brouwer J, Delewi R, et al. Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med 2020;382:1696-707.
79. Dangas GD, Tijssen JGP, Wöhrle J, et al. GALILEO Investigators. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med 2020;382:120-9.
80. Ten Berg J, Sibbing D, Rocca B, et al. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease. Eur Heart J 2021;42:2265-9.
81. Katz M, Carlos Bacelar Nunes Filho A, Caixeta A, et al. Brazilian TAVI Registry investigators. Gender-related differences on short- and long-term outcomes of patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2017;89:429-36.
82. Romano S, Buccheri S, Mehran R, Angiolillo DJ, Capodanno D. Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease. Expert Opin Drug Saf 2018;17:1041-52.
83. Nagao K, Taniguchi T, Morimoto T, et al. CURRENT AS Registry Investigators. Anemia in patients with severe aortic stenosis. Sci Rep 2019;9:1924.
84. Nicolas J, Claessen BE, Cao D, et al. Preprocedural anemia in females undergoing transcatheter aortic valve implantation: insights from the WIN-TAVI registry. Catheter Cardiovasc Interv 2021;97:E704-15.
85. Bière L, Launay M, Pinaud F, et al. Influence of sex on mortality and perioperative outcomes in patients undergoing TAVR: insights from the FRANCE 2 registry. J Am Coll Cardiol 2015;65:755-7.
86. Kodali S, Williams MR, Doshi D, et al. Sex-specific differences at presentation and outcomes among patients undergoing transcatheter aortic valve replacement: a cohort study. Ann Intern Med 2016;164:377-84.
87. Sannino A, Szerlip M, Harrington K, Schiattarella GG, Grayburn PA. Comparison of baseline characteristics and outcomes in men versus women with aortic stenosis undergoing transcatheter aortic valve implantation. Am J Cardiol 2018;121:844-9.
88. Doshi R, Shlofmitz E, Meraj P. Comparison of outcomes and complications of transcatheter aortic valve implantation in women versus men (from the national inpatient sample). Am J Cardiol 2018;121:73-7.
89. Stehli J, Dagan M, Zaman S, et al. Impact of gender on transcatheter aortic valve implantation outcomes. Am J Cardiol 2020;133:98-104.
90. Chandrasekhar J, Dangas G, Yu J, et al. STS/ACC TVT Registry. Sex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014. J Am Coll Cardiol 2016;68:2733-44.
91. Forrest JK, Adams DH, Popma JJ, et al. Transcatheter aortic valve replacement in women versus men (from the US CoreValve Trials). Am J Cardiol 2016;118:396-402.
92. D'Ascenzo F, Gonella A, Moretti C, et al. Gender differences in patients undergoing TAVI: a multicentre study. EuroIntervention 2013;9:367-72.
93. Buja P, Napodano M, Tamburino C, et al. Italian Multicenter CoreValve Registry Investigators. Comparison of variables in men versus women undergoing transcatheter aortic valve implantation for severe aortic stenosis (from Italian Multicenter CoreValve registry). Am J Cardiol 2013;111:88-93.
94. Humphries KH, Toggweiler S, Rodés-Cabau J, et al. Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol 2012;60:882-6.
